Jane Street’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.68M Buy
283,623
+62,197
+28% +$1.59M 0.01% 3089
2025
Q4
$6.43M Sell
221,426
-139,344
-39% -$3.57M 0.01% 2880
2025
Q3
$6.8M Buy
360,770
+233,648
+184% +$3.68M 0.01% 2956
2025
Q2
$1.78M Buy
127,122
+10,646
+9% +$149K ﹤0.01% 4601
2025
Q1
$1.82M Buy
116,476
+11,035
+10% +$155K ﹤0.01% 4514
2024
Q4
$1.47M Sell
105,441
-5,631
-5% -$61.7K ﹤0.01% 4677
2024
Q3
$1.03M Sell
111,072
-39,033
-26% -$385K ﹤0.01% 5822
2024
Q2
$1.4M Sell
150,105
-63,431
-30% -$574K ﹤0.01% 5130
2024
Q1
$2.12M Buy
213,536
+52,935
+33% +$395K ﹤0.01% 4026
2023
Q4
$519K Buy
160,601
+37,576
+31% +$102K ﹤0.01% 6698
2023
Q3
$653K Sell
123,025
-29,802
-20% -$253K ﹤0.01% 5849
2023
Q2
$1.46M Buy
152,827
+126,572
+482% +$1.4M ﹤0.01% 4634
2023
Q1
$289K Buy
+26,255
New +$380K ﹤0.01% 7264
2022
Q4
Sell
-19,081
Closed -$365K 9096
2022
Q3
$365K Buy
+19,081
New +$432K ﹤0.01% 7246
2022
Q2
Sell
-14,398
Closed -$295K 9608
2022
Q1
$277K Buy
+14,398
New +$244K ﹤0.01% 8523
2020
Q4
Sell
-10,959
Closed -$321K 7441
2020
Q3
$321K Buy
+10,959
New +$293K ﹤0.01% 5786

Other funds holding ARQT